The findings imply that enhanced renal ketogenesis due to Hmgcs2 overexpression may be significant in the pathogenesis of diabetic neuropathy DN in patients with type 2 diabetes, indicating that Hmgcs2 is a potential therapeutic target for the management of diabetic renal complications [19]. Here, HMGCS2 is linked to diabetes mellitus.